Most studies have looked at semaglutide as an adjunct to lifestyle modifications to rate its effectiveness in weight loss management and treatment
The study followed the CONSORT reporting guideline
With these assumptions, 1840 participants randomly assigned to semaglutide or placebo will provide 95% power to confirm superiority of semaglutide for the primary endpoint (change from baseline to week 104 in CDR-SB score)
People taking Ozempic, Wegovy, Mounjaro, Trulicity and Reybelsus may be at higher risk of developing gastroparesis
Some researchers find that they can reduce their dose to 1.7 mg after reaching their target and maintain results, though this should be discussed with a healthcare provider
Osmotic laxatives , particularly polyethylene glycol 3350 (MiraLAX), are generally recommended as first-line pharmacologic therapy